252 related articles for article (PubMed ID: 577556)
21. Twenty-four hour radioactive iodine uptake in 35 patients with amiodarone associated thyrotoxicosis.
Martino E; Aghini-Lombardi F; Lippi F; Baschieri L; Safran M; Braverman LE; Pinchera A
J Nucl Med; 1985 Dec; 26(12):1402-7. PubMed ID: 4067643
[TBL] [Abstract][Full Text] [Related]
22. Recombinant human thyrotropin administration enhances thyroid uptake of radioactive iodine in hyperthyroid cats.
van Hoek I; Daminet S; Vandermeulen E; Dobbeleir A; Duchateau L; Peremans K
J Vet Intern Med; 2008; 22(6):1340-4. PubMed ID: 18798789
[TBL] [Abstract][Full Text] [Related]
23. Transition of nodular toxic goiter to autoimmune hyperthyroidism triggered by 131I therapy.
Nygaard B; Faber J; Veje A; Hegedüs L; Hansen JM
Thyroid; 1999 May; 9(5):477-81. PubMed ID: 10365679
[TBL] [Abstract][Full Text] [Related]
24. The effect of recombinant human tsh on the thyroid (123)i uptake in iodide treated normal subjects.
Lawrence JE; Emerson CH; Sullaway SL; Braverman LE
J Clin Endocrinol Metab; 2001 Jan; 86(1):437-40. PubMed ID: 11232037
[TBL] [Abstract][Full Text] [Related]
25. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism.
Franklyn JA; Daykin J; Holder R; Sheppard MC
QJM; 1995 Mar; 88(3):175-80. PubMed ID: 7767667
[TBL] [Abstract][Full Text] [Related]
26. Post-ablative hypothyroidism.
Yaqub A; Choudhry MI; Wheaton J; Gress T
W V Med J; 2011; 107(2):37-40. PubMed ID: 21476476
[TBL] [Abstract][Full Text] [Related]
27. Increased Cardiovascular Mortality and Morbidity in Patients Treated for Toxic Nodular Goiter Compared to Graves' Disease and Nontoxic Goiter.
Giesecke P; Rosenqvist M; Frykman V; Friberg L; Wallin G; Höijer J; Lönn S; Törring O
Thyroid; 2017 Jul; 27(7):878-885. PubMed ID: 28471268
[TBL] [Abstract][Full Text] [Related]
28. The occurrence of hypothyroidism following radioactive iodine treatment of toxic nodular goiter is related to the TSH level.
Adamali HI; Gibney J; O'Shea D; Casey M; McKenna TJ
Ir J Med Sci; 2007 Sep; 176(3):199-203. PubMed ID: 17632747
[TBL] [Abstract][Full Text] [Related]
29. Glycemic status in hyperthyroid subjects.
Paul DT; Mollah FH; Alam MK; Fariduddin M; Azad K; Arslan MI
Mymensingh Med J; 2004 Jan; 13(1):71-5. PubMed ID: 14747791
[TBL] [Abstract][Full Text] [Related]
30. Adjuvant lithium improves the efficacy of radioactive iodine treatment in Graves' and toxic nodular disease.
Martin NM; Patel M; Nijher GM; Misra S; Murphy E; Meeran K
Clin Endocrinol (Oxf); 2012 Oct; 77(4):621-7. PubMed ID: 22443227
[TBL] [Abstract][Full Text] [Related]
31. [Clinical aspects of hyperthyroidism in areas of different supplies of iodine. Results of a European prospective study].
Reinwein D; Benker G; König MP; Pinchera A; Schatz H; Schleusener H
Schweiz Med Wochenschr; 1987 Aug; 117(34):1245-55. PubMed ID: 3672070
[TBL] [Abstract][Full Text] [Related]
32. [Biological investigation in hyperthyroidism].
Guinet P
Cah Med; 1972 Dec; 13(17):1235-42. PubMed ID: 4121374
[No Abstract] [Full Text] [Related]
33. Serum interleukin-6 in amiodarone-induced thyrotoxicosis.
Bartalena L; Grasso L; Brogioni S; Aghini-Lombardi F; Braverman LE; Martino E
J Clin Endocrinol Metab; 1994 Feb; 78(2):423-7. PubMed ID: 8106631
[TBL] [Abstract][Full Text] [Related]
34. Chronic lymphocytic thyroiditis, thyrotoxicosis, and low radioactive iodine uptake. Report of four cases.
Gluck FB; Nusynowitz ML; Plymate S
N Engl J Med; 1975 Sep; 293(13):624-8. PubMed ID: 1173935
[TBL] [Abstract][Full Text] [Related]
35. Iodine-131 given for therapeutic purposes modulates differently interferon-gamma-inducible alpha-chemokine CXCL10 serum levels in patients with active Graves' disease or toxic nodular goiter.
Antonelli A; Rotondi M; Fallahi P; Grosso M; Boni G; Ferrari SM; Romagnani P; Serio M; Mariani G; Ferrannini E
J Clin Endocrinol Metab; 2007 Apr; 92(4):1485-90. PubMed ID: 17244787
[TBL] [Abstract][Full Text] [Related]
36. Predictive factors of outcomes in personalized radioactive iodine ((131)I) treatment for Graves' disease.
Liu M; Jing D; Hu J; Yin S
Am J Med Sci; 2014 Oct; 348(4):288-93. PubMed ID: 24805788
[TBL] [Abstract][Full Text] [Related]
37. Radioiodine 131I treatment for large nodular goiter: recombinant human thyrotropin allows the reduction of radioiodine 131I activity to be administered in patients with low uptake.
Ceccarelli C; Antonangeli L; Brozzi F; Bianchi F; Tonacchera M; Santini P; Mazzeo S; Bencivelli W; Pinchera A; Vitti P
Thyroid; 2011 Jul; 21(7):759-64. PubMed ID: 21568727
[TBL] [Abstract][Full Text] [Related]
38. Enhanced thyroid iodine metabolism in patients with triiodothyronine-predominant Graves' disease.
Takamatsu J; Hosoya T; Naito N; Yoshimura H; Kohno Y; Tarutani O; Kuma K; Sakane S; Takeda K; Mozai T
J Clin Endocrinol Metab; 1988 Jan; 66(1):147-52. PubMed ID: 3335601
[TBL] [Abstract][Full Text] [Related]
39. [Metabolism of organic iodine studied after administration of labeled iodide].
Busnardo B; Casson F
Acta Isot (Padova); 1966 Dec; 6(2):129-47. PubMed ID: 4171572
[No Abstract] [Full Text] [Related]
40. [The treatment of hyperthyroidism with and indication for radioactive iodine].
Klokke AR; van der Vijver JC
Ned Tijdschr Geneeskd; 1995 Apr; 139(16):819-21. PubMed ID: 7537352
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]